not tagged
not tagged
['lymsm']
during the closed session, there was consensus on "level 1" topics but extreme disagreement on "level 3" topics, with the latter including refining ann arbor into just limited vs advanced stage disease. #lymsm #17icml 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈